Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ReproCELL Inc Amends Consolidated Mid-year Outlook for FY 2014


Friday, 1 Nov 2013 03:30am EDT 

ReproCELL Inc announced that it has lowered its consolidated mid-year outlook for revenue from JPY 194 million to JPY 186 million, ordinary profit from a loss of JPY 70 million to a loss of JPY 75 million, net profit from a loss of JPY 70 million to a loss of JPY 75 million and earning per share from a loss of JPY 1.73 to a loss of JPY 1.85, but raised the outlook for operating profit from a loss of JPY 65 million to a loss of JPY 43 million, for the fiscal year ending March 2014. The negative outlook is due to the stock split expenses and the initial public offering cost, and the positive outlook is due to the cost control. 

Company Quote

728.0
36.0 +5.20%
26 Dec 2014